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ABSTRACT
Background It is uncertain whether multiple health 
behaviour change (MHBC) interventions are effective for 
the primary prevention of cardiovascular disease (CVD) in 
primary care. A systematic review and a meta-analysis 
were performed to evaluate the effectiveness of MHBC 
interventions on CVD risk and CVD risk factors; the study 
also evaluated associations of theoretical frameworks and 
intervention components with intervention effectiveness.
Methods The search included randomised controlled 
trials of MHBC interventions aimed at reducing CVD risk 
in primary prevention population up to 2017. Theoretical 
frameworks and intervention components were evaluated 
using standardised methods. Meta-analysis with 
stratification and meta-regression were used to evaluate 
intervention effects.
Results We identified 31 trials (36 484 participants) with 
a minimum duration of 12 months follow-up. Pooled net 
change in systolic blood pressure (16 trials) was −1.86 
(95% CI −3.17 to −0.55; p=0.01) mm Hg; diastolic blood 
pressure (15 trials), −1.53 (−2.43 to −0.62; p=0.001) 
mm Hg; body mass index (14 trials), −0.13 (−0.26 to 
−0.01; p=0.04) kg/m2; serum total cholesterol (14 trials), 
−0.13 (−0.19 to −0.07; p<0.001) mmol/L. There was 
no significant association between interventions with 
a reported theoretical basis and improved intervention 
outcomes. No association was observed between 
intervention intensity (number of sessions and intervention 
duration) and intervention outcomes. There was significant 
heterogeneity for some risk factor analyses, leading to 
uncertain validity of some pooled net changes.
Conclusions MHBC interventions delivered to CVD-
free participants in primary care did not appear to have 
quantitatively important effects on CVD risk factors. Better 
reporting of interventions’ rationale, content and delivery is 
essential to understanding their effectiveness.
IntroductIon
Cardiovascular disease (CVD) is the leading 
cause of death worldwide, accounting for 
over 30% of global mortality.1 CVD is medi-
ated by several antecedent behavioural risk 
factors, and its onset might be prevented 
or delayed by altering one or several risk 
factors.1 Risk factors for CVD are inter-re-
lated and often coexist.2–4 This observation 
has informed the development of multiple 
health behaviour change (MHBC) interven-
tions for reduction of CVD risk. Identifying 
individuals at high risk of CVD in primary 
care, and encouraging lifestyle change to 
reduce risk factors, represents a widely used 
strategy for the primary prevention of CVDs. 
Randomised controlled trials have been 
conducted in primary care to evaluate the 
effectiveness of MHBC interventions using 
lifestyle modification techniques instead of, 
or in addition to, pharmacological treatment 
to modify CVD risk factors. These trials have 
generally provided only equivocal evidence 
for reduction of CVD incidence through 
MHBC but the degree of effectiveness might 
be associated with level of risk.5–7 Results 
from Ebrahim et al.’s5 systematic review 
suggested that MHBC interventions have 
negligible effect on mortality in unselected 
populations, with a pooled OR for coronary 
heart disease mortality of 0.99 (95% CI 0.92 
to 1.07). Evidence of benefit was found in 
studies in high-risk populations including 
people with hypertension (OR 0.78; 0.68 to 
0.89) or diabetes (OR 0.71; 0.61 to 0.83).5 
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Research
Strengths and limitations of this study
 ► The review presents evidence of head-to-head meta-
analysis of 31 published randomised controlled 
trials of multiple health behaviour change  (MHBC) 
interventions and cardiovascular risk with follow-up 
for 12 months or longer.
 ► The study employed standardised instruments to 
evaluate the impact of theory use and behaviour 
change techniques in MHBC interventions.
 ► The majority of trials included were conducted in 
Europe and United States and only English language 
publications were included.
 ► Not all studies evaluated all outcomes of interest 
and some lacked detail concerning intervention 
design and delivery.
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However, general health checks were not found to reduce 
all-cause mortality, nor CVD-related or cancer-related 
morbidity and mortality.8
Previous reviews have assessed the effectiveness of 
MHBC interventions in reducing CVD morbidity and 
mortality,5 6 8 and less is known about the effectiveness of 
these interventions in reducing CVD risk and risk factor 
values in primary care.
In recent years, there has been growing apprecia-
tion of the role of employing psychological theory in 
behaviour change intervention design and studying the 
impact of specific behaviour change techniques (BCTs) 
on intervention outcomes.9 Theories of the psycholog-
ical determinants of behaviour can be used to inform 
the development and evaluation of behaviour change 
interventions.10 Interventions are likely to be more 
effective when they systematically target psychological 
determinants of behaviour.11 A review of internet-based 
interventions suggested that more intensive use of theory 
was associated with greater behaviour change,12 but 
another review found little evidence of an association 
between theory use and intervention effects on healthy 
eating or physical activity.13 This equivocal evidence could 
arise if a high proportion of behaviour change inter-
ventions are not based on a theory or the theory is not 
applied extensively.14
BCTs are ‘the active components of an intervention 
designed to change behaviour’.15 Identifying specific 
BCTs associated with greater impact on intervention 
effectiveness is essential for future intervention design.16 
Previous reviews suggested that interventions using the 
BCTs ‘provision of instructions,’ ‘self-monitoring of 
behaviour,’ ‘relapse prevention’ and ‘prompt practice’ 
led to greater reductions in weight among obese individ-
uals,17 while interventions designed to modify physical 
activity and/or diet were more effective when they 
included self-monitoring plus one of the four following 
BCTs: prompting intention formation, specific goal 
setting, review of behavioural goals or providing feed-
back on performance.18 Identifying BCTs associated 
with greater intervention effectiveness and exploring the 
impact of applying theory will contribute to the design 
of future MHBC interventions targeting CVD risk in 
primary care.
objectives
This systematic review had three objectives: first, to assess 
the effectiveness of MHBC interventions, directed at 
changing two or more behaviours, at reducing CVD risk 
and CVD risk factors in adults without existing cardio-
vascular conditions; second, to evaluate whether using 
theory to develop interventions is associated with 
intervention effectiveness; and third, to evaluate the asso-
ciation between BCTs employed and intervention effects.
Methods
Studies were selected according to the criteria mentioned 
in the below sections.
Participants
Trials that recruited an adult population (>18 years old) 
free of CVD were included. Following previous reviews,5 
we included trials with less than 20% participants with 
CVD. Studies of patient populations with established 
disease, such as diabetes, were excluded.
Interventions
We included studies that evaluated behaviour change 
interventions aimed at reducing CVD risk by intervening 
on two or more risk behaviours at the same time. Risk 
behaviours included the following: physical activity, diet, 
alcohol consumption, use of stress management and 
smoking. Comparators were usual care or less intensive 
interventions.
settings
Interventions where participants were recruited, and 
interventions were delivered by trained healthcare profes-
sionals or primary care staff, in primary care premises 
(including general practice, family practice or primary 
care clinic).
study design
Controlled trials, with individual or cluster randomi-
sation, providing ≥12 months follow-up were used for 
outcome evaluation.
outcome measures
Long-term outcomes of MHBC interventions including 
CVD mortality and clinical events have been reported 
previously5 6 and only one study in 2015 included clinical 
events as an outcome. Therefore, long-term outcomes 
were not included in this systematic review. Primary 
outcomes were changes in CVD risk scores, body mass 
index (BMI) or body weight, blood pressure and serum 
total cholesterol levels. We have excluded diabetes 
management trials; therefore, diabetes control outcomes 
were not included. Secondary outcomes were changes in 
physical activity, diet, smoking and alcohol consumption.
Language
Studies reported in English.
search strategy
Multiple sources of ascertainment were used, including 
electronic databases (Medline, EMBASE, PsycINFO and 
CENTRAL) and searching reference lists of included 
papers. The search results and search terms of previous 
review5 were used with searching extended from 2006 
until February 2017. Search terms used included primary 
prevention, multiple risk factor, lifestyle intervention, 
health education and health promotion. (Online supple-
mentary appendix A presents the search strategies 
used.) Titles were screened by one reviewer (SA) and a 
second reviewer (MG) checked a random set of studies, 
approximately 10% of the search results, to assess agree-
ment regarding whether they met the inclusion criteria. 
Disagreements were resolved through discussion, until 
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Figure 1 Preferred Reporting Items for Systematic Reviews and Meta-Analyses flow diagram outlining the systematic review 
process.
full agreement was reached. The selection process is 
displayed in figure 1.
Methodological quality
Studies were evaluated using the Cochrane risk of bias 
tool.19 This assesses six domains of bias including selec-
tion bias, performance bias, detection bias, attrition bias, 
reporting bias and other biases.19
data extraction
Interventions were coded by country, target behaviours, 
participant and intervention characteristics, mode of 
delivery and intervention outcomes. We attempted to 
contact study authors to provide additional information 
where necessary. However, when information was not avail-
able, we assumed missing outcome data to occur at random.
In addition, Michie and Prestwich’s20 method of 
assessing the application of theory in the development 
and evaluation of behaviour change interventions was 
used. The Theory Coding Scheme (TCS) consists of 19 
items that cover different aspects that may be informed 
by theory.20 We used three measures to capture the extent 
of theory use, as employed in a previous review13: the first 
concerned whether the intervention was explicitly based 
on a theory or combination of theories or predictors 
(TCS item 5). Second, we assessed the degree to which 
each BCT reported as part of the intervention was linked 
to a theory-relevant construct (scored +2 for the ideal 
scenario of ‘yes’ to TCS item 7 (all intervention tech-
niques explicitly linked to at least one theory-relevant 
construct), +1 for studies coded ‘yes’ for TCS item 8 (at 
least one, but not all, intervention technique explicitly 
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Table 1 Summary of characteristics of 27 trials included in 
the review
Characteristics Freq. (%)
Total 31 (100)
Country UK 6 (19.4%)
Sweden 5 (16.1%)
Netherlands 4 (12.9%)
USA 4 (12.9%)
Europe 7 (22.6%)
Others 5 (16.1%)
Participants (n) Median (IQR) 419 (224–883)
Gender Male only 1 (3.2)
Female only 1 (3.2)
Both 29 (93.5)
Age Minimum age, 
median (IQR)
30 (20–40)
Maximum age, 
median (IQR)
65 (60–74)
Intervention 
outcomes
CVD risk 14 (45.2)
Body weight 25 (80.6)
Blood pressure 26 (83.9)
Serum cholesterol 26 (83.9)
Diet 18 (58.1)
Physical activity 21 (67.7)
Alcohol 6 (19.4)
Smoking 15 (48.4)
Targeted 
behaviours (n)
Two behaviours 11 (35.5)
Three behaviours 12 (38.7)
Four behaviours 7 (22.6)
Five behaviours 1 (3.2)
Follow-up duration 12 months 18 (58.1)
>12 months 13 (41.9)
Figures are frequencies (column percent).
CVD, cardiovascular disease.
linked to at least one theory-relevant construct) and/
or TCS item 9 (group of BCTs are linked to a group of 
constructs) and 0 for studies coded ‘no’ for all of items 
7–9). Finally, we rated the extent to which all constructs in 
the relevant theory had been explicitly targeted by BCTs. 
This was scored +2 for the ideal scenario of ‘yes’ to TCS 
item 10 (all theory-relevant constructs explicitly linked to 
at least one BCT), +1 for ‘yes’ to TCS item 9 (group of 
BCTs are linked to a group of constructs) and/or item 
11 (at least one, but not all, theory-relevant construct is 
explicitly linked to at least one BCT) and 0 for interven-
tions coded ‘no’ to all of items 9–11.
The theory-based taxonomy of 93 BCTs developed by 
Michie et al9 was used to identify intervention techniques. 
The assessment was completed by two researchers (LM and 
SA) with good agreement for intervention groups (77.8% 
agreement) and control groups (92.6% agreement). 
Discrepancies were discussed and resolved to reach full 
agreement. Intervention characteristics and BCTs were also 
extracted from descriptions of the control group because 
the chosen nature of the control group can influence the 
apparent effectiveness of interventions.21 Where detail of 
interventions was lacking, we attempted to contact study 
authors to provide additional information.
data analysis
Outcome data were combined in random effects 
meta-analyses using ‘metan’ commands in STATA. 
DerSimonian and Laird22 random effect models were 
chosen due to the considerable heterogeneity for certain 
outcomes. For continuous outcomes, we used mean 
changes in each trial arm to calculate net effects. We 
expressed effects for binary variables as risk differences. 
We quantified statistical heterogeneity using I2 statistic. 
We have examined the influence of individual studies in 
outcomes with considerable heterogeneity (I2 >50%) by 
omitting one study at a time to see the extent to which 
heterogeneity could be explained by a study or group on 
studies (leave-one-out analysis).
Meta-regression analyses were used to examine the 
effect of medication use, number of interventions’ 
sessions, intervention duration, types of BCTs used and 
theory use on intervention outcomes. Intervention 
duration was calculated by multiplying the number of 
sessions and the sessions’ duration. Publication bias was 
assessed using Egger’s regression test23 using ‘metabias’ 
and ‘metafunnel’ commands in STATA. If bias existed, 
the ‘trim and fill’24 method was used to adjust for publica-
tion bias. Mendis et al25 Nigeria site’s study had unusually 
high summary estimates, and heterogeneity diminished 
substantially after this study was excluded. This study was 
therefore treated as an outlier and results were reported 
with the exclusion of this study.
resuLts
The initial search identified 26 656 references, with 55 
relevant trials identified from the previous systematic 
review.5 After removing duplicates, 21 089 titles were 
screened. A total of 31 trials were included in this review 
(figure 1).
Included studies
We identified a total of 31 trials of MHBC intervention for 
the primary prevention of CVD in primary care with 36 484 
participants. The duration of follow-up ranged from 12 
months to 6 years (median=12 months). Intervention 
duration ranged from 2 months up to 3 years (median=12 
months). Summary of included studies characteristics is 
presented in table 1 and online  supplementary table 1.
study characteristics
Diet and physical activity were targeted in 11 trials, with 
nine trials targeting diet, physical activity and smoking. 
Diet, physical activity, smoking and alcohol consump-
tion were targeted in seven interventions and two 
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Table 2 Summary of interventions characteristics for 27 trials included in the review
Intervention
n (%)
Control
n (%)
Type of staff delivering intervention General practitioners and physicians 10 (32.3)
Nurses 15 (48.4)
Dietitian  7 (22.6)
Others 12 (38.7)
Mode of intervention delivery Face-to-face sessions 30 (96.8) 14 (45.2)
Group sessions 9 (29.0)  1 (3.2)
Written materials 15 (48.4) 7 (22.6)
Telephone sessions 8 (25.8) –
Unclear – 13 (41.9)
Intervention sessions (n) 1–4 sessions 5 (16.1) 9 (29.0)
5–9 sessions 11 (35.5)  2 (6.5)
10–15 sessions 4 (12.9)  1 (3.2)
>15 sessions 5 (16.1)  1 (3.2)
Unclear 6 (19.4) 18 (58.1)
 BCTs (n) 1–2 BCTs 5 (16.1) 14 (45.2)
3–4 BCTs 10 (32.3)  1 (3.2)
5–6 BCTs 12 (38.7) –
7–9 BCTs 3 (9.7) –
10 BCTs 1 (3.2) –
Unclear – 16 (51.6)
Frequently used BCTs Credible source (9.1) 22 (70.9) 6 (19.4)
Goal setting (behaviour) (1.1) 19 (61.3)  2 (6.5)
Information about health 
consequences (5.1)
9 (29.0) 5 (16.1)
Instruction on how to perform a 
behaviour (4.1)
9 (29.0)  1 (3.2)
Action planning (1.4) 9 (29.0) –
Self-monitoring of behaviour (2.3) 8 (25.8) –
Figures are frequencies (column percent)
BCT, behaviour change technique.
interventions targeted diet, physical activity and stress 
management. Only one intervention targeted diet, phys-
ical activity, stress and alcohol consumption and one 
intervention targeted all five behaviours. A wide range 
of intervention modalities was investigated (table 2 
and online supplementary table 2), including individual 
and group sessions, telephone conversations and provi-
sion of written materials. The majority of the included 
trials reported offering ‘usual care’ to the control group, 
with few details provided. Seven trials offered face-to-face 
sessions and seven trials offered face-to-face sessions and 
written materials. Written materials alone were offered in 
three trials and no intervention was offered to the control 
group in three interventions.
risk of bias in included studies
Risk of bias assessment is presented (online supplementary 
table 3). Half of the included trials (n=16) reported using 
intention-to-treat (ITT) analysis, while 15 studies did not 
state ITT procedures. Loss to follow-up ranged from 1.5% 
to 50.9%. Random allocation methods were not usually 
reported. In only 14 out of 31 trials, the method used was 
considered adequate. It is not possible to blind participants 
and personnel to treatment allocation in lifestyle interven-
tion, which raises the possibility of bias inevitably. Only five 
trials have reported blinding of participants and personnel. 
Eleven trials have reported blinding outcomes assessors 
to treatment allocation; this too makes the assessment of 
outcomes likely biased (eg, self-reported outcomes). Not 
all trials reported sufficient detail to assess risk of bias and 
these were rated as ‘unclear’.
treatment fidelity
Few studies reported using fidelity checks26–30 to confirm 
that interventions were delivered as intended and this 
group.bmj.com on August 4, 2017 - Published by http://bmjopen.bmj.com/Downloaded from 
6 Alageel S, et al. BMJ Open 2017;7:e015375. doi:10.1136/bmjopen-2016-015375
Open Access 
raises a question of whether the interventions were deliv-
ered as planned and in a consistent manner.
effect of interventions
Pooled effect sizes for all outcomes are presented in 
table 3 and forest plots are presented (online supplemen-
tary appendix B).
changes in cVd risk factors
Blood pressure
Sixteen trials25 27 31–44 reported changes in participants’ 
systolic blood pressure (SBP) with no evidence of publi-
cation bias (Egger’s test, p=0.79). The weighted mean 
difference in SBP was −1.86 mm Hg (95% CI −3.17 to 
−0.55 mm Hg; p=0.01). Diastolic blood pressure (DBP) 
was reported in 15 trials,25 27 31–33 35–44 with no evidence 
of publication bias (Egger’s test, p=0.19). Weighted mean 
difference in DBP was −1.53 mm Hg (−2.43 to −0.62 mm 
Hg; p=0.001). Out of the 12 interventions that evaluated 
blood pressure, seven reported that participants in all 
study groups were taking antihypertensive medications 
and three reported that they were taking unspecified medi-
cations. There are no significant differences between the 
impact of trials that reported use of medication on SBP 
(β=−1.72; p=0.23) and DBP (β=−1.46; p=0.12) compared 
with trials that did not report using medications.
Serum total cholesterol
Fourteen trials27 31–33 35–37 39–45 evaluated serum total choles-
terol and provided sufficient data for analysis (Egger’s 
test, p=0.55). Serum total cholesterol levels showed a 
small decrease in favour of intervention (−0.13 mmol/L; 
95% –0.19 to −0.07; p<0.001). Six of the trials included in 
the analysis reported the use of lipid lowering medication 
and two reported the use of unspecified medication by 
all study groups. The weighted mean difference for total 
cholesterol was not different between trials that reported 
using medication and trials that have not stated using 
medications (β=0.01; p=0.75) (table 3).
Smoking
Eleven studies25 26 29–32 34 37 44 46 47 reported smoking prev-
alence following the intervention. The pooled analysis 
showed no evidence of reductions in smoking behaviour 
(risk difference −0.00%; 95% CI −0.02 to 0.01; p=0.66). 
All studies included in the analysis relied on self-reported 
smoking status and only two29 44 reported using smoking 
cessation medication. There was no evidence of publica-
tion bias (p=0.47).
Weight and BMI
Fourteen studies25 27 31 33 35–44 reported on BMI as an 
outcome. The weighted mean change was −0.13 kg/m2 
(95% CI −0.26 to −0.01; p=0.04). The results of ‘trim and fill’ 
method indicated that the weighted mean did not change 
despite the existence of publication bias (Egger’s test, 
p=0.002). Fewer studies (n=12)27 33 35–37 40–44 47 48 reported 
on weight changes, showing a reduction of −0.91 kg (CI 
−1.39 to −0.43 kg; p<0.001) with no evidence of publica-
tion bias (p=0.97).
Dietary behaviour
Sixteen trials25–30 33 34 42–45 47–50 reported dietary behaviours 
as an outcome of the interventions. Outcomes of dietary 
interventions were measured using diverse methods; 
therefore, a meta-analysis was not conducted. Trials 
used a range of dietary self-report instruments to assess 
dietary behaviour, and none has used additional objective 
measures. Fruit and vegetable consumption was reported 
either as portions per day25–27 43 47 50 or as proportion of 
participants who met the recommendation for fruits and 
vegetable intake.26 33 34 There was no positive effect of the 
intervention on fruits and vegetable consumption in most 
of the trials,26 27 34 47 and some trials did report improve-
ment following the intervention.33 43 50 Fat intake was 
commonly measured as a dietary outcome either in terms 
of fat intake per day27 33 48 49 or as a fat score.29 34 All the 
trials reported reductions in fat intake after the interven-
tion, except Koelewijn-van Loon et al34 trial, where there 
was no significant difference between the intervention 
and control group.
Physical activity behaviour
Twenty trials reported changes in physical 
activity.26–34 36 37 39 40 42–44 46 47 50 51 Physical activity was 
assessed via self-report. Due to the variety of measurements 
used, meta-analysis was not feasible. Some trials reported 
physical activity as the proportion of participants who are 
physically active.29 31 39 46 50 Other studies measured physical 
activity as the number of minutes per week,27 34 42 43 or clas-
sified participants based on their weekly exercise.26 28 44 50 
Eight of these trials27 29 30 36 37 40 42 44 47 50 resulted in an 
increase in reported physical activity following the inter-
vention, and nine26 28 31–33 39 43 46 48 51 trials concluded that 
the intervention had no impact on physical activity.
Alcohol consumption
Alcohol consumption was reported as an outcome in 
seven trials.30 34 40 46–48 50 However, it was measured differ-
ently, which did not allow for pooled effect analysis. Two 
trials40 46 reported reductions in alcohol consumption 
following the interventions, whereas the majority of the 
studies30 34 47 48 50 did not find significant reductions in 
alcohol intake.
CVD risk
Studies used different risk scores to examine the effect of 
interventions on CVD risk. Two studies38 51 used the Fram-
ingham risk equation,52 two studies30 53 used the Dundee 
Risk Score54 and one study44 used QRISK2 score.55 These 
trials reported larger CVD risk reductions in the inter-
vention group compared with the control group. All of 
these trials had missing data making it not possible to 
analyse the pooled effect. Four studies26 34 39 46 used the 
SCORE risk56; however, because of missing data, we only 
included two studies26 34 in the analysis, both conducted 
in the Netherlands. There was a non-significant increase 
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in weighted mean difference of 0.12% CVD risk (95% CI 
−0.37 to 0.61; p=0.62).
sensitivity analysis
In outcomes of considerable heterogeneity (I2 >50%), 
we sought to identify possible causes by exploring the 
effect of included studies using leave-one-out sensitivity 
analysis. The absence of study Mendis et al (China site)25 
and Koelewijn-van Loon et al34 in analysing the impact 
of interventions of SBP reduces heterogeneity from 
I2=63% to I2=49.4% and generated a weighted mean 
difference (−1.86; CI −3.17 to −0.54; p=0.001) similar to 
the one obtained with all 16 trials. For DBP, removing 
Knutsen and Knutsen31 from the analysis has resulted in 
reducing heterogeneity from I2=68.3% to I2=37.8% and 
produced a larger weighted mean difference (−1.93; CI 
−2.69 to −1.18; p<0.001).
Intervention components
Intervention time and number of sessions
The number of sessions was reported in 24 trials, ranging 
from 3 to 56 sessions (median=6 sessions). No signifi-
cant associations were detected between the number 
of sessions and SBP (β=−0.17; p=0.15), DBP (β=−0.15; 
p=0.08), BMI (β=−0.01; p=0.57) and weight (β=0.02; 
p=0.68). Interventions with more sessions were associated 
with slight reductions in serum total cholesterol (β=−0.01; 
p=0.02). Thirteen of the included trials provided enough 
details to calculate intervention delivery duration, which 
ranged from 45 min to 2.5 hours (median=300 min). No 
significant associations were detected between interven-
tion duration and SBP (β=−0.00; p=0.26), DBP (β=−0.00; 
p=0.45), BMI (β=−0.00; p=0.53) and weight (β=−0.00; 
p=0.55). Hence, more sessions and longer intervention 
duration were not necessarily associated with greater 
intervention effectiveness.
Theory use
Of the 31 trials included, nine reported some use of 
psychological theory (or a combination of two theories) 
in relation to the intervention. The Transtheoretical 
Model57 was used in eight trials,27 28 36–40 47 while Social 
Cognitive Theory58 was used in four27 28 38 59 interventions.
We tested the extent of theory use using TCS20 in three 
ways (see online supplementary table 4). The first method 
was based on the use of theory in selecting intervention 
techniques (item 5 in TCS). Only four trials were coded 
yes for this item. The second method was used to reflect 
the extent to which reported BCTs were linked to theo-
ry-relevant constructs (items 7–9). Only four trials were 
coded yes to at least one of these items. The third method 
was used to reflect the extent to which all theory-relevant 
constructs were targeted by BCTs (items 9–11). Only 
four trials were coded yes to at least one of these items. 
Therefore, we were not able to examine the impact of 
differing levels of theory use on intervention outcomes 
due to the small number of trials using theory extensively. 
However, we were able to test whether studies that merely 
reported using a theory had greater impact on outcomes 
using meta-regression. There was no significant associa-
tion between studies which reported using a theory and 
SBP (β=−0.13; p=0.89), DBP (β=−0.37; p=0.73) and BMI 
(β=−0.03; p=0.87). Studies that reported using a theory 
had increased weight (β=1.07; p=0.03; CI 0.11 to 2.04) 
and serum total cholesterol outcomes (β=0.19; p=0.04) 
compared with studies that did not report using a theory.
Effectiveness of specific BCTs
The number of BCTs in the intervention group varied, 
ranging from 2 to 10 BCTs (median=5). BCTs in the 
control group were generally poorly described as the 
majority of trials (n=16) did not appear to offer any BCTs.
Twenty-nine different BCTs were identified from the 
included trials (see online supplementary table 2). The 
most commonly used BCTs in the intervention group 
were ‘credible source’ and ‘Goal setting (behaviour)’, 
which were used in 22 and 19 trials, respectively. In the 
control group, ‘Credible source’ and ‘Information about 
health consequences’ were most commonly used, which 
were used in six and five interventions, respectively.
We tested the potential impact of using specific BCTs 
on intervention outcomes (table 4). For SBP, one BCT 
had a significant influence on effect sizes. Interventions 
employing ‘Review of behaviour goal(s)’ resulted in an 
increase in SBP (β=3.45; p=0.04) compared with those 
not using this BCT. For DBP and total cholesterol, there 
were no BCTs significantly associated with the effective-
ness of the interventions. The same was the case for BMI, 
but for weight, interventions that included ‘Action plan-
ning’ resulted in greater reductions than those that did 
not (β=−1.10; p=0.04).
dIscussIon
This systematic review is among the first to evaluate the 
impact of theory use and BCTs in MHBC interventions 
for reducing CVD risk, although pooled effects of inter-
ventions on risk factors were statistically significant but 
clinically modest. The results of this systematic review 
suggest that MHBC interventions evaluated to date for 
the primary prevention of CVD may generally have very 
limited effects in reducing CVD risk and CVD risk factors 
in primary care populations.
Previous systematic reviews have investigated the effec-
tiveness of interventions aimed at individual risk factors 
including diet, physical activity and body weight.6 60 These 
reviews generally find that behaviour change interven-
tions in primary care have minor impact on risk factor 
values. The Cochrane review up to 2011 reported modest 
reductions in CVD risk factors following MHBC interven-
tions that were slightly greater than we report.5 However, 
the Cochrane review did not restrict the intervention 
setting to primary care.
Estimated changes in CVD risk factors should be viewed 
with caution. In the present set of trials, the average 
duration of follow-up was 12 months and changes in risk 
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factors observed may be unlikely to reflect changes occur-
ring over longer periods. This review found reductions in 
blood pressure and total cholesterol following interven-
tion, but in some instances, this might be mediated by 
pharmacological treatment. There are clear benefits of 
drug treatments in lowering blood pressure and choles-
terol in primary prevention populations.61 62
Although this review focused on interventions for the 
primary prevention population, we also included trials 
that recruited a small minority of participants with some 
evidence of CVD. Including these trials might have biased 
the results, as health promotion interventions might have 
more positive effects in people with established CVD.63–65
In order to account for heterogeneity, we focused on 
trial level covariates and identified characteristics that 
might be associated with more favourable outcomes. 
When coding BCTs, we were limited by the lack of detail 
provided in reports. We only coded what was explicitly 
referred to in intervention descriptions and could be 
fitted to BCT taxonomy definitions.
This review suggested no association between the 
number of intervention sessions or intervention duration 
and improved outcomes. Quantity of sessions would not 
necessarily have a beneficial impact on outcomes unless 
additional sessions deliver BCTs that effectively influence 
behaviours. Few reports provided sufficient information 
to permit calculating duration for analysis. Increasing use 
of the Template for Intervention Description and Replica-
tion (TIDieR) checklist,66 requiring intervention reports 
to detail the number and duration of sessions offered to 
participants, will be helpful for future reviews.
Our analyses suggested that using certain BCTs has a 
moderator effect on intervention outcomes. In terms of 
biomarkers of CVD risk, no BCTs were identified as being 
particularly likely to influence cholesterol levels, while 
including review of behaviour goals appeared to be asso-
ciated with slightly worse blood pressure outcomes.
‘Action planning’ was associated with greater weight 
loss, while ‘Instruction on how to perform the behaviour’ 
was not. Both of these findings differ to those of a previous 
review,17 perhaps because it focused only on interven-
tions for obese individuals. The previous review also 
identified the BCTs of self-monitoring, relapse preven-
tion/problem solving and prompt practice as beneficial 
to weight loss, but too few of the interventions included 
in the present review incorporated these BCTs for it to 
be possible to test their influence. A review of interven-
tions promoting healthy eating and exercise also found 
that including the BCT of self-monitoring was associated 
with bigger changes in these behaviours.18 Therefore, 
one explanation for the relatively limited effectiveness of 
the interventions reviewed in the present review is that 
they failed to include BCTs that were more likely to lead 
to health-promoting changes. A second possibility is that 
not all BCTs were delivered as the intervention designers 
intended. This cannot be ruled out as monitoring of 
treatment fidelity was rarely described in the included 
studies.
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This review showed no association between the use 
of psychological theory and improved intervention 
outcomes. However, only a limited range of theories were 
employed—mostly the Transtheoretical Model and Social 
Cognitive Theory. A previous review also found that inter-
ventions based on these theories were not significantly 
more effective than interventions not explicitly based 
on theory.13 A second issue is that the links between the 
psychological determinants specified by a theory and the 
BCTs employed in interventions were sometimes poorly 
articulated, with little evidence cited to justify choice of 
BCTs to change specific constructs. Furthermore, it was 
not always clear which BCTs were being used to target 
which behaviours as part of the MHBC interventions. 
Both this and previous reviews13 67 found that reported 
theory use in intervention design was not as extensive as 
it could be. It is possible that interventions based on other 
theories or that more explicitly link theoretical constructs 
to select BCTs might be more effective.
Future trials need to test interventions that provide 
explicit links between intervention components (ie, theo-
retical basis, BCTs and intended mechanisms of action, 
intervention duration) and intervention outcomes as it is 
essential step towards understanding MHBC intervention 
effects. Higher priority should also be given to different 
population-level approaches to facilitate behaviour 
change.
Limitations
The results of this review must be viewed with caution 
because of several limitations. First, the observed effects 
were heterogeneous; therefore, pooled estimates might 
be questionable. DerSimonian and Laird (DL)22 random 
effects models were used. The DL method may lead 
to under-estimation of between-trial variance leading 
to narrower CIs in the presence of heterogeneity.68 69 
However, Thorlund et al70 concluded that infer-
ences concerning pooled effects were only infrequently 
influenced by the choice of between-trial variance esti-
mator. The majority of trials included were undertaken 
in Europe (71%) and the United States (13%). Declines 
in CVD mortality and CVD risk have been observed in 
these countries, and the results should be considered in 
the context of these trends. Groups of BCTs may have 
synergistic effects on behaviour.16 However, due to the 
relatively small numbers of studies and under-description 
of the BCTs used in interventions, it was not possible to 
explore the impact of clusters of BCTs on CVD risk factors, 
as too few studies used the same clusters of BCTs and 
measured the same outcome. Furthermore, the differ-
ences between subgroups and covariates (ie, theory use 
and BCTs) and effect size are observational and do not 
imply causality. Behavioural risk factors were assessed by 
self-report and so values were subject to social desirability 
and recall biases. Finally, as this review involved testing 
for the impact of MHBC interventions and intervention 
characteristics on intervention outcomes, we are aware 
of the need to adjust p values based on the number of 
tests being made.71 Although adjusting p values reduces 
type 1 error, it increases the chances of false negatives.72 
Furthermore, tests were examining independent hypoth-
eses; therefore, p values were not adjusted.73
concLusIon
Existing MHBC interventions delivered to individual 
participants in primary care appear to have limited 
effectiveness at reducing CVD risk and CVD risk factors 
over 12 months or longer. Trial reports need to provide 
explicit explanation of the intervention theory, content 
and delivery, including fidelity and care provided to the 
control group in order to understand why an intervention 
may or may not prove effective. This is essential for future 
development and evaluation of effective CVD prevention 
interventions.
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